The functional consequence of this selective gain-of-function in CARD11 recruitment in mice is to correct the majority of activation and differentiation defects caused by CD28 deficiency or by the absence of the CD80 and CD86 ligands including Treg cell development and tumor eradication. This evidence concerns the gene CD28 and neoplasm.